About Cardival Medical
Cardival Medical is a company based in Santa Clara (United States) founded in 2002 was acquired by Haemonetics in January 2021. Cardival Medical has raised $169.45 million across 13 funding rounds from investors including Haemonetics, GE Capital and WI Harper Group. The company has 158 employees as of December 31, 2022. Cardival Medical offers products and services including Cell Saver, TEG 6s, and VASCADE. Cardival Medical operates in a competitive market with competitors including TISSIUM, Laminate Medical, Vivasure Medical, Saranas and Aziyo Biologics, among others.
- Headquarter Santa Clara, United States
- Employees 158 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cardiva Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$169.45 M (USD)
in 13 rounds
-
Latest Funding Round
$45 M (USD), Series E
Jul 14, 2020
-
Investors
Haemonetics
& 9 more
-
Employee Count
158
as on Dec 31, 2022
-
Acquired by
Haemonetics
(Jan 20, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cardival Medical
Cardival Medical offers a comprehensive portfolio of products and services, including Cell Saver, TEG 6s, and VASCADE.
Device for recovering blood during surgical procedures
System for monitoring and analyzing blood clotting functions
Tool for sealing vascular access sites post-procedure
Funding Insights of Cardival Medical
Cardival Medical has successfully raised a total of $169.45M across 13 strategic funding rounds. The most recent funding activity was a Series E round of $45 million completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cardival Medical
Cardival Medical has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Haemonetics, GE Capital and WI Harper Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm investing in expansion & late stage start-ups in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investment management services are provided by Luther King Capital Management.
|
Locked | Locked | Locked |
Investor details for Cardival Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cardival Medical
Investment portfolio details for Cardival Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cardival Medical
Detailed financials for Cardival Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cardival Medical Comparisons
Peer comparison for Cardival Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cardival Medical
Cardival Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TISSIUM, Laminate Medical, Vivasure Medical, Saranas and Aziyo Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vascular sealants for open surgery are developed by TISSIUM.
|
|
| Locked | Locked | Locked |
AV fistula maturation and patency are supported by VasQ device.
|
|
| Locked | Locked | Locked |
Bioabsorbable implants and delivery systems for arteriotomy closure are developed.
|
|
| Locked | Locked | Locked |
A device is developed for detecting internal bleeding during catheterization.
|
|
| Locked | Locked | Locked |
Regenerative medicine products are developed for orthopedic and cardiovascular applications.
|
Detailed competitors of Cardival Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cardival Medical
Complete news archive for Cardival Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cardival Medical
Cardival Medical was founded in 2002 and raised its 1st funding round 1 year after it was founded.
Cardival Medical is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
Cardival Medical is a funded company, having raised a total of $169.45M across 13 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Cardival Medical is 158.
Cardival Medical was founded in 2002 in Santa Clara, United States, where medical devices for vascular access are developed. Operations center on two products: Vascade, an extravascular bioabsorbable femoral access closure system, and CATALYST, used for temporary hemostasis and coagulation support in patients. The focus remains on vascular sector innovations, with activities based in the United States.
Cardival Medical's top competitors include TISSIUM, Vivasure Medical and Aziyo Biologics.
Cardival Medical offers Cell Saver, TEG 6s, and VASCADE.
Cardival Medical has 10 investors. Key investors include Haemonetics, GE Capital, WI Harper Group, PTV Healthcare Capital, and Canepa Healthcare.